LOW GRADE SEROUS OVARIAN CANCER
Clinical trials for LOW GRADE SEROUS OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new LOW GRADE SEROUS OVARIAN CANCER trials appear
Sign up with your email to follow new studies for LOW GRADE SEROUS OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-stage trial tests a combination of two experimental drugs, defactinib and VS-6766, in people with advanced solid tumors that have stopped responding to standard treatments. The study includes patients with certain lung, ovarian, endometrial, and pancreatic cancers. The…
Matched conditions: LOW GRADE SEROUS OVARIAN CANCER
Phase: PHASE1 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated May 17, 2026 11:39 UTC
-
New hope for rare ovarian cancer: drug combo tested in japanese patients
Disease control OngoingThis study tests a combination of two drugs, avutometinib and defactinib, in 16 Japanese patients whose low-grade serous ovarian cancer has come back after prior treatment. The goal is to see if the drugs can shrink or control the tumors. Participants must have a specific KRAS ge…
Matched conditions: LOW GRADE SEROUS OVARIAN CANCER
Phase: PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC